Abstract
Introduction: In the UK, 4.9 million people have type 2 diabetes mellitus (T2DM), costing the NHS £10 billion annually. In England, one in six people (17.0%) has experienced depression or anxiety in the past 12 months. T2DM is managed by pharmacological therapy and lifestyle adjustment.
Objectives: This study aimed to explore if there is a relationship between depression, anxiety and poor medication adherence in patients diagnosed with T2DM. This was a pilot, single-site, observational study of patients with T2DM (n=64) randomly assigned into group A (three consultations) or group B (two consultations). All initial consultations were in-person, while follow-ups were by telephone. The measurable outcomes were changes in HbA1c, BP, and self-reported well-being. Thematic and comparative analysis was conducted by groups and demographic variables using paired sample t-test and statistical regression.
Methods: A scoping study was also carried out to identify gaps in the current literature and understand the T2DM and MIH comorbidity trends in the local population from the West Midlands, UK,to inform future studies. The reviewed studies reported a relationship between T2DM control and depression and anxiety but disagreed on its significance. The clinical audit of 71 patients diagnosed with T2DM showed that 73% of males presented with poor diabetes control (HbA1c>7) compared to females (46%). Conversely, females exhibited a higher prevalence of MIH (45%) than males (31%).
Results: The overall study showed that BP readings were unchanged but remained in the recommended range for both groups, under 130/82 mmHg. Based on the manual thematic coding, there were three possible phenomena(high self-care efficacy and favourable disease prognosis [F=7 & M=4], high self-care efficacy and poor disease prognosis [F= 15 & M=11] and poor self-care efficacy and poor disease prognosis[F=12 & M=11]) and one phenomenon was not proven due to the small sample size and possible patients self-reporting bias (poor self-care efficacy and favourable disease prognosis [F=1 & M=3]).More frequent interventions were advantageous.
Conclusions: Two prototype T2DM management algorithms were created, which were generic and tailored to patients from Pakistani and Bangladeshi backgrounds. These were adopted in the study site and were provided to the HRA in the final ethics report for NHS use in wider primary care. Other ethnicities and chronic conditions could be similarly investigated.
Objectives: This study aimed to explore if there is a relationship between depression, anxiety and poor medication adherence in patients diagnosed with T2DM. This was a pilot, single-site, observational study of patients with T2DM (n=64) randomly assigned into group A (three consultations) or group B (two consultations). All initial consultations were in-person, while follow-ups were by telephone. The measurable outcomes were changes in HbA1c, BP, and self-reported well-being. Thematic and comparative analysis was conducted by groups and demographic variables using paired sample t-test and statistical regression.
Methods: A scoping study was also carried out to identify gaps in the current literature and understand the T2DM and MIH comorbidity trends in the local population from the West Midlands, UK,to inform future studies. The reviewed studies reported a relationship between T2DM control and depression and anxiety but disagreed on its significance. The clinical audit of 71 patients diagnosed with T2DM showed that 73% of males presented with poor diabetes control (HbA1c>7) compared to females (46%). Conversely, females exhibited a higher prevalence of MIH (45%) than males (31%).
Results: The overall study showed that BP readings were unchanged but remained in the recommended range for both groups, under 130/82 mmHg. Based on the manual thematic coding, there were three possible phenomena(high self-care efficacy and favourable disease prognosis [F=7 & M=4], high self-care efficacy and poor disease prognosis [F= 15 & M=11] and poor self-care efficacy and poor disease prognosis[F=12 & M=11]) and one phenomenon was not proven due to the small sample size and possible patients self-reporting bias (poor self-care efficacy and favourable disease prognosis [F=1 & M=3]).More frequent interventions were advantageous.
Conclusions: Two prototype T2DM management algorithms were created, which were generic and tailored to patients from Pakistani and Bangladeshi backgrounds. These were adopted in the study site and were provided to the HRA in the final ethics report for NHS use in wider primary care. Other ethnicities and chronic conditions could be similarly investigated.
| Original language | English |
|---|---|
| Pages | 19 |
| Number of pages | 1 |
| Publication status | Published - 2023 |
| Event | FIP Pharmacy Practice Research summer meeting 2023: for PhD students, postdoctoral fellows and supervisors - University of Granada, Granada, Spain Duration: 03 Jul 2023 → 04 Jul 2023 https://fip.eventsair.com/2023-ppr-summer-meeting/ https://pharmacyeducation.fip.org/pharmacyeducation/article/view/2435/1595 (Published abstracts) |
Other
| Other | FIP Pharmacy Practice Research summer meeting 2023 |
|---|---|
| Country/Territory | Spain |
| City | Granada |
| Period | 03/07/23 → 04/07/23 |
| Other | The FIP Pharmacy Practice Research Special Interest Group (PPR SIG), in collaboration with University of Granada, is hosting an international event — “Pharmacy practice research summer meeting for PhD students, postdoctoral fellows and supervisors” — on 3 and 4 July 2023 in Granada, Spain. The main scope of the PPR SIG is to increase pharmacy practice contributions to global health by providing greater access to the latest high-quality international pharmacy practice research. During this meeting both starting-out and experienced researchers will be able to collaborate on major PPR themes. PhD students and their supervisors, researchers, academics, professional organisations and practitioners involved in research are welcome to join this face-to-face meeting to present their work and to start building new global pharmacy networks. Accepted abstracts will be published in the Pharmacy Education journal. Selected authors will be invited to present their work either through poster or oral presentation and interact with the audience during the event. The best presentations will receive an award. Certificates of attendance and presentations will be provided. |
| Internet address |
